HUT51299A - Process for producing peptolides containing pipecholic acid and pharmaceutical compositions containing them as active components - Google Patents

Process for producing peptolides containing pipecholic acid and pharmaceutical compositions containing them as active components Download PDF

Info

Publication number
HUT51299A
HUT51299A HU894797A HU479789A HUT51299A HU T51299 A HUT51299 A HU T51299A HU 894797 A HU894797 A HU 894797A HU 479789 A HU479789 A HU 479789A HU T51299 A HUT51299 A HU T51299A
Authority
HU
Hungary
Prior art keywords
formula
compound
group
substituents
alkyl
Prior art date
Application number
HU894797A
Other languages
English (en)
Hungarian (hu)
Inventor
Michael M Dreyfuss
Klaus Rueedi
Hans Tscherter
Gerhard Emmer
Maximilian Grasseberger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUT51299A publication Critical patent/HUT51299A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU894797A 1988-09-23 1989-09-08 Process for producing peptolides containing pipecholic acid and pharmaceutical compositions containing them as active components HUT51299A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3832362A DE3832362A1 (de) 1988-09-23 1988-09-23 Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
HUT51299A true HUT51299A (en) 1990-04-28

Family

ID=6363573

Family Applications (1)

Application Number Title Priority Date Filing Date
HU894797A HUT51299A (en) 1988-09-23 1989-09-08 Process for producing peptolides containing pipecholic acid and pharmaceutical compositions containing them as active components

Country Status (18)

Country Link
US (1) US5643869A (fr)
EP (1) EP0360760B1 (fr)
JP (1) JPH02134399A (fr)
KR (1) KR900004739A (fr)
AT (1) ATE118506T1 (fr)
AU (1) AU628855B2 (fr)
CA (1) CA1340447C (fr)
DE (2) DE3832362A1 (fr)
DK (1) DK466989A (fr)
ES (1) ES2068913T3 (fr)
FI (1) FI894480A7 (fr)
HU (1) HUT51299A (fr)
IL (1) IL91708A (fr)
MY (1) MY105028A (fr)
NZ (1) NZ230728A (fr)
PT (1) PT91776B (fr)
TW (1) TW224427B (fr)
ZA (1) ZA897249B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
DK223690D0 (da) * 1990-09-17 1990-09-17 Novo Nordisk As Hidtil ukendte forbindelser
WO1993012659A1 (fr) * 1991-12-20 1993-07-08 Novo Nordisk A/S Utilisation dans l'agriculture de certains composes et compositions; procedes de production desdits composes
AU702332B2 (en) * 1994-07-27 1999-02-18 Novartis Ag Organic compounds
US6011136A (en) * 1995-11-21 2000-01-04 Novartis Ag Cyclopeptolides
AU1683599A (en) * 1997-12-18 1999-07-05 Ajinomoto Co., Inc. Cyclopeptolides
AU3837600A (en) * 1999-04-16 2000-11-02 Sankyo Company Limited Novel antifungal compounds
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
GB0113663D0 (en) * 2001-06-05 2001-07-25 Novartis Ag Use of organic compounds
KR101110262B1 (ko) * 2005-12-20 2012-02-15 재단법인 포항산업과학연구원 스트레인 신호증폭기의 자동보정 방법
KR101646694B1 (ko) 2014-11-18 2016-08-09 김동열 양말 지그와 이를 이용한 양말 인쇄 시스템
BR112019013234A2 (pt) * 2017-01-05 2020-02-11 National Institute Of Advanced Industrial Science And Technology Gene envolvido na síntese de composto peptídico cíclico, método para produção do composto peptídico cíclico usando o mesmo, e transformante compreendendo o mesmo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585111A (en) * 1968-03-04 1971-06-15 Upjohn Co Process for making antibiotic sphaeropsidin
US4582639A (en) * 1984-06-18 1986-04-15 Bristol-Myers Company Antitumor antibiotic compound
DD238068A5 (de) * 1984-10-09 1986-08-06 ���@�����@�K@�������k�� Verfahren zur herstellung von derivaten der cyclopeptidantibiotika a-21978 c

Also Published As

Publication number Publication date
PT91776B (pt) 1995-05-31
EP0360760A3 (en) 1990-10-10
DE68921128T2 (de) 1995-09-14
NZ230728A (en) 1993-02-25
DE3832362A1 (de) 1990-03-29
PT91776A (pt) 1990-03-30
AU4165289A (en) 1990-04-05
FI894480A0 (fi) 1989-09-21
AU628855B2 (en) 1992-09-24
KR900004739A (ko) 1990-04-12
DE68921128D1 (de) 1995-03-23
ATE118506T1 (de) 1995-03-15
US5643869A (en) 1997-07-01
MY105028A (en) 1994-07-30
ES2068913T3 (es) 1995-05-01
FI894480L (fi) 1990-03-24
DK466989A (da) 1990-03-24
FI894480A7 (fi) 1990-03-24
DK466989D0 (da) 1989-09-21
EP0360760B1 (fr) 1995-02-15
ZA897249B (en) 1991-05-29
IL91708A (en) 1994-05-30
IL91708A0 (en) 1990-06-10
CA1340447C (fr) 1999-03-16
TW224427B (fr) 1994-06-01
JPH02134399A (ja) 1990-05-23
EP0360760A2 (fr) 1990-03-28

Similar Documents

Publication Publication Date Title
FI60032C (fi) Foerfarande foer framstaellning av nytt terapeutiskt verkande cyklosporin g
US5166135A (en) Method for the control of pneumocystis carinii
EP0359529B1 (fr) Méthode de contrôle de Pneumocystis carinii
US5643869A (en) Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
EP0448355A2 (fr) Agents antibiotiques
AU639698B2 (en) Antibiotic agent
TRAXLER et al. Papulacandins-synthesis and biological activity of papulacandin B derivatives
US5386009A (en) Lipopeptide derivatives
CZ231896A3 (en) Antiphlogistic cyclic heptapeptide
JPH04217697A (ja) 抗生物質
AU675651B2 (en) Novel antibiotics with immunosuppressive activity, delaminomycins, and production thereof
JP3067869B2 (ja) 抗生物質
WO2000032587A1 (fr) Substances sf2809-i, ii, iii, iv, v et vi presentant une activite d'inhibition de la chymase
US5366880A (en) Antibiotic agent
KR960016206B1 (ko) Bu-3862t 항종양 항생제
EP0318254B1 (fr) Dérivés de tripeptides
JPS61145145A (ja) アントラサイクリン誘導体およびそれらの微生物学的製法
PL164143B1 (pl) Sposób wytwarzania nowych peptolldów zawierających kwas pipekollnowy
KR100474161B1 (ko) 에어로트리신 유도체, 이의 제조 방법 및 이를 함유하는 약학조성물
JP2000510450A (ja) 群体ホヤ類のリッソクリヌム種からの環状ヘプタ―ペプチド誘導体
SU1403991A3 (ru) Способ получени ингибитора фермента превращени ангиотензина и штамм стрептомицета SтRертомYсеS снRомоFUSсUS NRRL 15098,используемый дл его осуществлени
EP0432697A2 (fr) Antibiotique BU-4146T
WO1993014111A1 (fr) Nouveau compose appele ustiloxine a ou b, ou son derive
CA2224025A1 (fr) Feglymycine, nouvel antibiotique; methode de preparation et utilisation
JPH11130795A (ja) Ｙｍ−１７５２０１物質

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment